← Back to contracts

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

US National Institutes of Health (NIDA – National Institute on Drug Abuse) grant open #PAR-24-269
Response due Feb 11, 2027 · 00:00 UTC

Summary

The National Institute on Drug Abuse (NIDA), part of NIH/HHS, is soliciting research applications under the Animal Genomics Program using the U01 cooperative agreement mechanism. Clinical trials are explicitly not allowed under this funding opportunity. The program supports genomics-related research utilizing animal models, likely in the context of substance use and addiction science. The opportunity was posted in August 2024 and remains open through February 2027.

What they want

Technical requirements
  • Clinical trials are not allowed
  • Research must involve animal genomics
  • Cooperative agreement (U01) mechanism required

Risks & flags

  • No dollar value or award ceiling disclosed in the notice
  • Multi-year open window (Aug 2024–Feb 2027) with rolling submissions may favor established NIH-funded labs with pre-existing infrastructure

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

NIDA Animal Genomics Program (U01 Clinica…
Due Feb 11
Onboard